Navigation Links
FDA Panel Backs Tougher Warning for Tamiflu
Date:11/27/2007

Advisers say current labeling doesn't reflect reports of bizarre behaviors and sudden deaths

TUESDAY, Nov. 27 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel recommended Tuesday that the prescription flu drug Tamiflu (oseltamivir) should have a stronger warning label to reflect reports of bizarre behaviors and deaths among children who use the medication.

The FDA's Pediatric Advisory Committee, in a 9-5 vote, said that drug maker Roche Holding AG should change its prescribing information because it doesn't adequately explain side effects reported by hundreds of patients in Japan and the United States, according to Bloomberg News.

The drug's label mentions reports of delirium and self-injury, primarily among children in Japan, but the advisory panel said the language should state that several patients died as a result of these behaviors, the Associated Press reported.

In addition, the panel recommended that labeling for the flu drug Relenza, (zanamivir), should also reflect reports of abnormal behavior, according to Bloomberg.

The FDA is not obliged to follow its expert panels' recommendation, but it usually does. A safety review released Friday by the FDA's Division of Antiviral Products urged stronger label warnings for both drugs, including stricter monitoring of children taking these drugs.

According to the FDA safety review, there have been 596 reported cases of psychiatric behavior associated with Tamiflu use. Most of these cases happened among patients aged 21 or younger. The majority (75 percent) occurred in Japan.

Fifty-nine of the cases were classified as delirium with impulsive behavior and self-injury. Delirium, delusions, hallucinations or psychosis accounted for another 225 cases. In total, five children died "as a result of falls from windows or balconies or running into traffic," the safety review found, and three adul
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
2. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
3. Patient Safety Authority Board of Directors Names Infection Advisory Panel
4. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
5. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
6. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
7. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
8. Health Courts Critic to be Featured Speaker at Wyoming Patient Safety Panel
9. FDA Panel Mulls Ban on Kids Cold Medicines
10. FDA Panel Weighs Ban on Kids Cold Medicines
11. FDA Panel Recommends Ban on Cold Medicines for Kids
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Panel Backs Tougher Warning for Tamiflu
(Date:8/31/2015)... ... 31, 2015 , ... On Saturday, July 11, 2015, during the annual New ... City, NYSATA was proud to recognize Dr. Merritt F. Spear as the 2015 recipient ... named after long-time NYSATA member and Ithaca College athletic trainer and educator, is considered ...
(Date:8/31/2015)... ... 31, 2015 , ... All birth control methods work best if used correctly ... among birth control methods. Moreover, no-scalpel vasectomy has many proven advantages with a lower ... vasectomy done because they are afraid of complications. , One Stop Medical Center ...
(Date:8/31/2015)... Charleston, SC (PRWEB) , ... August 31, 2015 , ... ... is making it their business to help small businesses operate as efficiently and cost ... They've already made an impact in their first year of operation – and ...
(Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... Avid collector ... and the Doors Shrine Auditorium concert posters. This hand colored artwork is one of ... 23 in Los Angles. Hawley states, "When the doors played the Shrine, the ...
(Date:8/30/2015)... ... August 31, 2015 , ... Intellitec Solutions, based ... & Expo October 5th & 6th in San Antonio, TX. Dedicated to bringing ... industry professionals from all over the country come to share the latest and ...
Breaking Medicine News(10 mins):Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3Health News:One Stop Medical Center of Twin Cities Achieves Zero Failure Rate and Infection Rate in No Scalpel Vasectomy 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 3Health News:Intellitec Solutions to feature Microsoft Dynamics GP at AHCA/NCAL 66th Annual Convention & Expo 2
... , FRIDAY, Dec. 30 (HealthDay News) -- New research suggests ... cause, multiple sclerosis also damages the part of the brain ... "The thalamus is a central area that relates to the ... study co-author Khader Hasan, an associate professor at University of ...
... , FRIDAY, Dec. 30 (HealthDay News) --,Binge drinking ... study. Researchers looked at 208 unmarried heterosexual dating couples ... five days a week. At least one member of each ... had dated for a minimum of three months and an ...
... There are many ways to prevent spreading germs and disease, ... one of the most important: proper hand-washing. This ... get together for parties and other celebrations, researchers at the ... is the single most effective way to prevent the spread ...
... Researchers have identified six risk factors linked to blindness after ... ischemic optic neuropathy, or ION, the complication occurs when the ... estimated to occur in as many as one in 1,000 ... at any age, according to researchers. For the new ...
... (December 29, 2011) Two recent studies by Van ... more complete understanding of distinct kidney cancer subtypes, which could ... published in Cancer Cell led by Kyle Furge, ... understanding of the biology of Type 2 papillary renal cell ...
... By E.J. Mundell HealthDay Reporter , THURSDAY, Dec. ... in 2011, the ongoing debate over the legality of the new ... case now set to go to the U.S. Supreme Court early ... Care Act , which President Obama signed into law in 2010, ...
Cached Medicine News:Health News:Multiple Sclerosis May Cause Changes in Thalamus: Study 2Health News:Hand-Washing Key to Stopping Spread of Disease 2Health News:Risk Factors for Vision Loss After Spine Surgery Identified 2Health News:Van Andel Research Institute findings provide more complete picture of kidney cancer 2Health News:Health Care Reform Battle Tops Health News for 2011 2Health News:Health Care Reform Battle Tops Health News for 2011 3
(Date:8/30/2015)... 2015 La solución de ... cuidado al paciente a lo ... Royal Philips  (NYSE: PHG, AEX: PHIA) ... Cardiovascular , un sistema web de gestión de imágenes ... y compartir imágenes cardiovasculares e información en cualquier momento, ...
(Date:8/28/2015)... 2015  CytomX Therapeutics, Inc., a biopharmaceutical company developing ... the filing of a registration statement on Form S-1 ... to a proposed initial public offering of its common ... the price range for the offering have not yet ... under the symbol "CTMX" on the NASDAQ Global Market. ...
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "12th ... and Production" report to their offering. ... of Biopharmaceutical Manufacturing Capacity and Production is the ... manufacturing organizations, current and projected future capacity and ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3CytomX Files Registration Statement for Proposed Initial Public Offering 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
... KINNELON, N.J., Sept. 8, 2011 Life Recovery Systems ... three-year agreement by Premier Purchasing Partners, LP, the group ... the ThermoSuit System available by contract to its more ... award, LRS,s first GPO contract, Robert Neary, LRS Director ...
... Elusys Therapeutics, Inc. (Elusys), a  biopharmaceutical company developing ... awarded the first U.S. Government contract to develop ... use via intramuscular injection (IM). The five year ... multiple animal efficacy studies as well as human ...
Cached Medicine Technology:Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 2Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 3Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection 2Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: